The "Liptonorm" drug is an instruction for use as a lipid-lowering drug, which is part of the pharmacological group of statins. The administration of this drug has a pronounced positive effect on the state of atheroma and vascular walls, normalizes the function of the endothelium, and also significantly improves the rheological characteristics of the blood. In addition, the "Liptonorm" (application instruction explains this with the action of the active ingredient) has pronounced antiproliferative and antioxidant properties and is able in a relatively short time to reduce the level of cholesterol in people suffering from familial hypercholesterolemia of the homozygous type. At the same time, the action of this drug is based on the inhibition of the enzyme, which stimulates the conversion of HMG-CoA into the so-called mevalonic acid.
The hypolipidemic agent "Liptonorm" is produced, the price of which is approximately two hundred fifty to three hundred rubles today, in the form of biconvex white dragees, containing in its composition atorvastatin in the amount of ten or twenty milligrams. Additional ingredients are lactose, calcium carbonate, Tween 80, hydroxypropylmethyl cellulose, microcrystalline cellulose, polyethylene glycol, magnesium stearate, hydroxypropylcellulose, titanium dioxide and crosscarmellose.
Experts generally recommend taking Liptonorm tablets to people with established primary or family hypercholesterolemia of heterozygous and homozygous type. In addition, this tool very well helps patients with mixed hyperlipidemia.
Use the drug "Liptonorm" instructions for use strictly does not recommend in the presence of severe liver disease (including chronic alcoholic hepatitis or active chronic hepatitis), liver failure or cirrhosis. In case of allergic reaction to atorvastatin or individual intolerance of any of the auxiliary components presented in the preparation, it is also worthwhile to refrain from taking this medication from the statin group. In addition, it should not be prescribed to patients under the age of eighteen years and to women who carry the child. People with increased activity of hepatic transaminases of unknown origin should likewise not take such tablets as "Liptonorm." The instructions for use, included in the kit, do not recommend using them during the lactation period. With great caution, it is necessary to prescribe this lipid-lowering drug to people with severe forms of electrolyte balance disorders, arterial hypotension, endocrine or metabolic abnormalities. In addition, the list of relative contraindications includes chronic alcoholism, uncontrolled seizures, sepsis, as well as extensive injuries and surgical interventions.